First Time Loading...

Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 109.29 USD -0.92% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC

Wall Street analysts forecast JAZZ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JAZZ is 189.78 USD with a low forecast of 122.21 USD and a high forecast of 241.5 USD.

JAZZ Lowest Forecast
Wall Street Target
122.21 USD
12% Upside
JAZZ Average Forecast
Wall Street Target
189.78 USD
74% Upside
JAZZ Highest Forecast
Wall Street Target
241.5 USD
121% Upside
Lowest
Price Target
122.21 USD
12% Upside
Average
Price Target
189.78 USD
74% Upside
Highest
Price Target
241.5 USD
121% Upside

JAZZ Last Price Targets
Jazz Pharmaceuticals PLC

The latest public price target was made on May 2, 2024 by Daniel Busb from RBC Capital , who expects JAZZ stock to rise by 61% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Daniel Busb
RBC Capital
176 USD
Upside 61%
1 day ago
May 2, 2024
Jazz Pharmaceuticals (JAZZ) PT Lowered to $176 at RBC Capital
StreetInsider
David Amsellem
Piper Sandler
188 USD
Upside 72%
1 month ago
Mar 20, 2024
Jazz Pharmaceuticals (JAZZ) PT Raised to $188 at Piper Sandler
StreetInsider
Daniel Busb
RBC Capital
Price Target 176 USD
Upside/Downside 61%
View Source
David Amsellem
Piper Sandler
Price Target 188 USD
Upside/Downside 72%
View Source
Jazz Pharmaceuticals PLC Competitors:
Price Targets
2348
Dawnrays Pharmaceutical (Holdings) Ltd
133% Upside
D
170900
Dong-A ST Co Ltd
35% Upside
MEDCL
Medincell SA
22% Upside
H
3692
Hansoh Pharmaceutical Group Company Ltd
2% Upside
2348
Dawnrays Pharmaceutical (Holdings) Ltd
133% Upside
D
170900
Dong-A ST Co Ltd
35% Upside
MEDCL
Medincell SA
22% Upside
H
3692
Hansoh Pharmaceutical Group Company Ltd
2% Upside
NGM
NGM Biopharmaceuticals Inc
10% Upside
CPH
Cipher Pharmaceuticals Inc
36% Upside
OCUL
Ocular Therapeutix Inc
169% Upside
LLY
Eli Lilly and Co
12% Upside

Revenue
Forecast

Revenue Estimate
Jazz Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's revenue is 14%. The projected CAGR for the next 3 years is 7%.

14%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Jazz Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's operating income is 2%. The projected CAGR for the next 3 years is 45%.

2%
Past Growth
45%
Estimated Growth
Estimates Accuracy
-44%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Jazz Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's net income is 3%. The projected CAGR for the next 3 years is 49%.

3%
Past Growth
49%
Estimated Growth
Estimates Accuracy
-46%
Average Miss
What are analyst estimates?

See Also

Summary
JAZZ intrinsic value, competitors valuation, and company profile.
DCF Valuation
JAZZ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
JAZZ stock valuation using valuation multiples.
Wall Street Estimates
JAZZ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
JAZZ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JAZZ's stock price target?
Price Target
189.78 USD

According to Wall Street analysts, the average 1-year price target for JAZZ is 189.78 USD with a low forecast of 122.21 USD and a high forecast of 241.5 USD.

What is Jazz Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's revenue is 14%. The projected CAGR for the next 3 years is 7%.

What is Jazz Pharmaceuticals PLC's Operating Income forecast?
Projected CAGR
45%

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's operating income is 2%. The projected CAGR for the next 3 years is 45%.

What is Jazz Pharmaceuticals PLC's Net Income forecast?
Projected CAGR
49%

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's net income is 3%. The projected CAGR for the next 3 years is 49%.

ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.